305 related articles for article (PubMed ID: 20090218)
1. Sinonasal malignancies with neuroendocrine differentiation: case series and review of literature.
Menon S; Pai P; Sengar M; Aggarwal JP; Kane SV
Indian J Pathol Microbiol; 2010; 53(1):28-34. PubMed ID: 20090218
[TBL] [Abstract][Full Text] [Related]
2. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype.
Rosenthal DI; Barker JL; El-Naggar AK; Glisson BS; Kies MS; Diaz EM; Clayman GL; Demonte F; Selek U; Morrison WH; Ang KK; Chao KS; Garden AS
Cancer; 2004 Dec; 101(11):2567-73. PubMed ID: 15517582
[TBL] [Abstract][Full Text] [Related]
3. A clinicopathological study of sinonasal neuroendocrine carcinoma and sinonasal undifferentiated carcinoma.
Smith SR; Som P; Fahmy A; Lawson W; Sacks S; Brandwein M
Laryngoscope; 2000 Oct; 110(10 Pt 1):1617-22. PubMed ID: 11037813
[TBL] [Abstract][Full Text] [Related]
4. Does sophisticated diagnostic workup on neuroectodermal tumors have an impact on the treatment of esthesioneuroblastoma?
Haas I; Ganzer U
Onkologie; 2003 Jun; 26(3):261-7. PubMed ID: 12845211
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine Carcinoma and Sinonasal Undifferentiated Carcinoma.
Abdelmeguid AS; Bell D; Hanna EY
Adv Otorhinolaryngol; 2020; 84():168-184. PubMed ID: 32731236
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy.
van der Laan TP; Iepsma R; Witjes MJ; van der Laan BF; Plaat BE; Halmos GB
Oral Oncol; 2016 Dec; 63():1-9. PubMed ID: 27938993
[TBL] [Abstract][Full Text] [Related]
7. Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses.
Babin E; Rouleau V; Vedrine PO; Toussaint B; de Raucourt D; Malard O; Cosmidis A; Makaeieff M; Dehesdin D
J Laryngol Otol; 2006 Apr; 120(4):289-97. PubMed ID: 16526967
[TBL] [Abstract][Full Text] [Related]
8. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis.
Ejaz A; Wenig BM
Adv Anat Pathol; 2005 May; 12(3):134-43. PubMed ID: 15900114
[TBL] [Abstract][Full Text] [Related]
9. The importance of multimodality therapy in the treatment of sinonasal neuroendocrine carcinoma.
van der Laan TP; Bij HP; van Hemel BM; Plaat BE; Wedman J; van der Laan BF; Halmos GB
Eur Arch Otorhinolaryngol; 2013 Sep; 270(9):2565-8. PubMed ID: 23740425
[TBL] [Abstract][Full Text] [Related]
10. Sinonasal Small Cell Carcinoma-Case Series of a Rare Malignancy.
Chapurin N; Totten DJ; Louis PC; Lewis JS; Chowdhury NI; Turner J; Chandra RK
Ear Nose Throat J; 2022 Jul; 101(6):392-395. PubMed ID: 33090899
[TBL] [Abstract][Full Text] [Related]
11. Sinonasal neuroendocrine carcinoma: a population-based analysis of incidence and survival.
Patel TD; Vazquez A; Dubal PM; Baredes S; Liu JK; Eloy JA
Int Forum Allergy Rhinol; 2015 May; 5(5):448-53. PubMed ID: 25727332
[TBL] [Abstract][Full Text] [Related]
12. A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes.
De Cecco L; Serafini MS; Facco C; Granata R; Orlandi E; Fallai C; Licitra L; Marchesi E; Perrone F; Pilotti S; Quattrone P; Piazza C; Sessa F; Turri-Zanoni M; Battaglia P; Castelnuovo P; Antognoni P; Canevari S; Bossi P
Oral Oncol; 2019 Mar; 90():94-101. PubMed ID: 30846184
[TBL] [Abstract][Full Text] [Related]
13. Sinonasal Carcinomas with Neuroendocrine Features: Histopathological Differentiation and Treatment Outcomes.
Soldatova L; Campbell RG; Carrau RL; Prevedello DM; Wakely P; Otto BA; Filho LF
J Neurol Surg B Skull Base; 2016 Dec; 77(6):456-465. PubMed ID: 27857871
[No Abstract] [Full Text] [Related]
14. Role of p40 and cytokeratin 5/6 in the differential diagnosis of sinonasal undifferentiated carcinoma.
Singh L; Ranjan R; Arava S; Singh MK
Ann Diagn Pathol; 2014 Oct; 18(5):261-5. PubMed ID: 25017972
[TBL] [Abstract][Full Text] [Related]
15. Genetic profiling of poorly differentiated sinonasal tumours.
López-Hernández A; Vivanco B; Franchi A; Bloemena E; Cabal VN; Potes S; Riobello C; García-Inclán C; López F; Llorente JL; Hermsen M
Sci Rep; 2018 Mar; 8(1):3998. PubMed ID: 29507386
[TBL] [Abstract][Full Text] [Related]
16. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
[TBL] [Abstract][Full Text] [Related]
17. Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas.
López L; Fernández-Vañes L; Cabal VN; García-Marín R; Suárez-Fernández L; Codina-Martínez H; Lorenzo-Guerra SL; Vivanco B; Blanco-Lorenzo V; Llorente JL; López F; Hermsen MA
J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888115
[TBL] [Abstract][Full Text] [Related]
18. Small cell neuroendocrine carcinoma of nose and paranasal sinuses: The Shaukat Khanum Memorial Cancer Hospital experience and review of literature.
Faisal M; Haider I; Adeel M; Waqas O; Hussain R; Jamshed A
J Pak Med Assoc; 2018 Jan; 68(1):133-136. PubMed ID: 29371736
[TBL] [Abstract][Full Text] [Related]
19. Sinonasal undifferentiated carcinoma: clinicopathological spectrums and diagnosis reappraisal.
Vaziri Fard E; Zhang S; Cai Z; Ding J; Sun Q; Saluja K; Zhu H
Hum Pathol; 2019 Jul; 89():62-70. PubMed ID: 31054892
[TBL] [Abstract][Full Text] [Related]
20. IDH2 -Mutated Sinonasal Tumors: A Review.
Alzumaili B; Sadow PM
Adv Anat Pathol; 2023 Mar; 30(2):104-111. PubMed ID: 36537260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
